Oral norovirus vaccine to enter Phase 1b trial
by Press Release from Outbreak News Today on (#4BG0G)
The bivalent Norovirus GII.4 oral tablet vaccine developed by Vaxart is moving forward-the initiation of a Phase 1b clinical trial. "The initiation of the bivalent norovirus vaccine Phase 1b trial marks a significant step towards our goal of developing a vaccine that can protect the most vulnerable patients from this highly infectious disease," said Wouter ["]
The post Oral norovirus vaccine to enter Phase 1b trial appeared first on Outbreak News Today.